Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3780733 | 0.85 | LTA4H (0.61) | LTA4HNPC1RAB9AATMTDO2 | |
| Hydrochloric Acid SCHEMBL2463750 | 0.83 | LTA4H (0.59) | LTA4HNPC1RAB9AATMTDO2 | |
| SCHEMBL3906600 | 0.81 | LTA4H (0.57) | LTA4HNPC1RAB9AATMTDO2 | |
| SCHEMBL3345523 | 0.80 | LTA4H (0.56) | LTA4HTAAR1NPC1RAB9AKDM4E | |
| SCHEMBL5925309 | 0.79 | LTA4H (0.54) | LTA4HNPC1RAB9AATMKDM4E | |
| SCHEMBL15244880 | 0.79 | TAAR1 (0.48) | TAAR1ADRA2CHTR2ASMN1; SMN2HRH1 | |
| SCHEMBL5925318 | 0.77 | LTA4H (0.53) | LTA4HNPC1RAB9AATMKDM4E | |
| SCHEMBL5023959 | 0.77 | LTA4H (0.66) | LTA4HNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL6028964 | 0.77 | LTA4H (0.61) | LTA4HNPC1RAB9AATMTDO2 | |
| SCHEMBL4846964 | 0.77 | LTA4H (0.61) | LTA4HNPC1RAB9AATMTDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0659737-B1 | Catecholamine surrogates useful as beta 3 agonists | BRISTOL MYERS SQUIBB CO (US) | 2003-03-26 | — | — | EP | disclosed |
| US-5776983-A | ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0557305-B1 | (2-THIENYL) ALKYLAMINE DERIVATIVES HAVING NEUROPROTECTIVE PROPERTIES | ASTRA AB (SE) | 1997-06-11 | — | — | EP | disclosed |
| EP-0659737-A2 | Catecholamine surrogates useful as B3 agonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| EP-0172692-B1 | HEXAHYDROINDOLIZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS AND INTERMEDIATES | McNeilab, Inc. (US) | 1990-04-18 | — | — | EP | disclosed |
| EP-0322582-A2 | 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-07-05 | — | — | EP | disclosed |
| EP-0172692-A1 | Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates | McNeilab, Inc. (US) | 1986-02-26 | — | — | EP | disclosed |
| US-4572911-A | ANTISECRETORY AND ANTIDEPRESSANT AGENTS | MCNEILAB, INC. (US) | 1986-02-25 | — | — | US | disclosed |